Sai Life Sciences Limited has informed the Exchange regarding allotment of 25000 securities pursuant to ESOP/ESPS at its meeting held on May 13, 2025
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences Limited has allotted 25,000 fully paid-up equity shares of Re.1 each on May 13, 2025, following the exercise of employee stock options. This includes 20,000 shares under the Management ESOP Plan 2018 at an exercise price of Rs 23.30 per share, and 5,000 shares under ESOP 2008 at Rs 188.90 per share. The company realized a total of Rs 14.10 lakh (Rs 4.66 lakh from ESOP 2018 and Rs 9.44 lakh from ESOP 2008) through these exercises. After this allotment, the total issued share capital stands at 20,84,85,899 equity shares. The shares have been issued in demat form and carry no lock-in restrictions.
This is a routine ESOP allotment with no material impact on shareholders. The dilution from 25,000 shares is negligible relative to the ~20.85 crore total share base. The low exercise prices relative to likely market value suggest these are long-vested older grants, indicating stable employee retention.